• Novartis hit by court loss, could spur numerous cases across industry pharmafile
    December 25, 2017
    In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held liable for medical complications that occur from a generic equivalent, if they are found to have inadequately labelled the original product.
PharmaSources Customer Service